Pfizer's 2022 sales forecast disappoints investors
Shares of Pfizer fell after the drugmaker's forecast for this year's sales of its COVID-19 vaccine and antiviral pills came in below Wall Street estimates.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook